| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 05/16/2002 | WO2001079209A3 Diazafluorenone il-8 antagonists |
| 05/16/2002 | WO2001079195A3 Pyridine and pyrazine derivatives as thrombin inhibitors |
| 05/16/2002 | US20020058155 Cyclic tertiary amine compound and organic electroluminescent device containing the compound |
| 05/15/2002 | EP1204675A1 Streptogramin derivatives, production thereof and compositions containing the same |
| 05/15/2002 | EP1204642A1 Fungicides |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/15/2002 | CN1349538A Cyclocarbamate and cyclic amide derivatives |
| 05/15/2002 | CN1349537A Cyclic urea and cyclic amide derivatives |
| 05/15/2002 | CN1349412A Contraceptive compositions containing cyclic urea and amide derivatives |
| 05/14/2002 | US6387920 Isoxazole compounds; for treating estrogen receptor-mediated disorders such as osteoporosis, breast and endometrial cancers, atherosclerosis, alzheimer's disease |
| 05/14/2002 | US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/14/2002 | US6387918 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 05/10/2002 | WO2001097809A3 Method of treating cardiovascular disease using rapamycin |
| 05/10/2002 | WO2001081342A3 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use |
| 05/10/2002 | WO2001041780A3 Use of an immunosuppressant for increasing an antifugal activity of a lipopeptide |
| 05/10/2002 | WO2001029036A3 Allosteric sites on muscarinic receptors |
| 05/09/2002 | US20020055518 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease. |
| 05/09/2002 | US20020055508 Benzofurazan compounds which enhance AMPA receptor activity |
| 05/09/2002 | US20020055502 New compounds, their preparation and use |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1202985A2 Chemokine receptor antagonists |
| 05/08/2002 | EP0737197B1 Amino alkanoic esters of rapamycin |
| 05/08/2002 | CN1348454A Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 05/07/2002 | US6384218 Prepared by reacting amino acid, oligo- or polypeptide or polyamino acid with trialdehyde; molecular recognition agent for use in neurotransmission studies |
| 05/07/2002 | US6384073 Use of macrolide compounds for treating glaucoma |
| 05/07/2002 | US6384050 Tricyclic amine derivatives |
| 05/07/2002 | US6384046 Treating neointimal proliferation and thickening |
| 05/07/2002 | CA2216535C Protein kinase c inhibitors |
| 05/07/2002 | CA2098612C Arthropodicidal carboxanilides |
| 05/02/2002 | WO2002034718A1 Amide derivatives as nmda receptor antagonists |
| 05/02/2002 | WO2002002562A3 Heteropolycyclic inhibitors |
| 05/02/2002 | US20020052364 Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors |
| 05/02/2002 | EP1201718A2 Mixed crystals of benzimidazoloneoxazine derivatives |
| 05/02/2002 | EP1201670A2 Process for preparing 2-oxaisocephem derivatives |
| 05/02/2002 | EP1201668A1 Staurosporin derivatives |
| 05/02/2002 | EP1200447A1 Oxazinocarbazoles for the treatment of cns diseases |
| 05/02/2002 | EP0888359B1 Pyrimidin-4-one derivatives as pesticide |
| 05/02/2002 | EP0812838B1 Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor |
| 05/02/2002 | DE10052221A1 Verfahren zur Herstellung neuer Kristallmodifikationen eines methylsubstituierten Benzimidazolon-Dioxazin-Pigmentes Process for the preparation of new crystal forms of a methyl-substituted benzimidazolone-dioxazine pigment |
| 04/30/2002 | USRE37686 Biosynthesis of polypeptides |
| 04/30/2002 | US6380228 E.g., n-(2-phenylsulfonyl-1-ethyl)-3-(4-cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/30/2002 | US6380178 Cyclic regimens using cyclocarbamate and cyclic amide derivatives |
| 04/30/2002 | US6380134 N-pyridyl herbicide compounds |
| 04/30/2002 | US6379823 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 04/25/2002 | WO2002032904A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents |
| 04/25/2002 | WO2002032893A2 Piperidine compounds as anti-allergic |
| 04/25/2002 | WO2001087283A3 New use of citreamicins |
| 04/25/2002 | WO2001081341A3 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations |
| 04/25/2002 | US20020049327 Such as 7-(3-chlorophenyl)-9-((4-chlorophenyl)-1H-imidazol-1-ylmethyl)-2,3-dihydro -1H,5H-benzo(ij)quinolizin-5-one; for forming oncogenes for signalling transformation of tumor cells |
| 04/25/2002 | US20020049242 Condensed 4,5,6,7-tetrahydrobenzo[C]thiopenes as enhancer for cell differentiation induction factor action |
| 04/25/2002 | US20020049203 CRF receptor antagonists and methods relating thereto |
| 04/25/2002 | US20020049197 Aminoquinazolines and their use as medicaments |
| 04/25/2002 | DE10052858A1 Mixed crystals of different benzimidazolone-dioxazine compounds give fast red shades e.g. for pigmenting plastics or use in toners or developers, are obtained by co-synthesis, acidic cyclization, precipitation or sublimation |
| 04/25/2002 | CA2426103A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents |
| 04/24/2002 | EP1199309A1 Process for producing new crystalline modifications of a methyl-substituted benzimidazolonedioxazine pigment |
| 04/24/2002 | EP1199306A1 Biarylurea derivatives |
| 04/24/2002 | EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 04/24/2002 | CN1346074A Silver halide picture photosensitive material, compound forming azoheterocyclic dye, and process for preparing dye |
| 04/24/2002 | CN1083453C Fused imidazole derivatives as emultidrug resistance modulators |
| 04/23/2002 | US6376656 Disazo dyes, triazine dyes |
| 04/23/2002 | US6376517 For treating vision loss, preventing vision degeneration, and promoting vision regeneration (?neopsis?) |
| 04/23/2002 | US6376487 Oxadiazine derivatives |
| 04/18/2002 | WO2002030938A1 Benzhydryl derivatives |
| 04/18/2002 | WO2002030925A1 Benzopyranyl heterocycle derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
| 04/18/2002 | WO2002002541A3 Inhibitors of copper-containing amine oxidases |
| 04/18/2002 | WO2001087830A3 Substituted thioacetamides |
| 04/18/2002 | WO2001077112A3 Photochromic spiro(indoline)naphthoxazines |
| 04/18/2002 | US20020045759 E.g., N-(2-Phenylsulfonyl-1-ethyl)-3-(4-Cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta |
| 04/18/2002 | US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/18/2002 | US20020044967 Sustained release preparations |
| 04/17/2002 | EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 04/17/2002 | EP1196170A2 New use of a macrolide compound for treating neurodegenerative disorders |
| 04/17/2002 | EP0804186B1 Indole diterpene alkaloid compounds |
| 04/17/2002 | CN1082963C Isoxazolidine derivatives |
| 04/16/2002 | US6372775 Reversal of multidrug resistance in human colon carcinoma cells |
| 04/11/2002 | WO2002028867A2 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 04/11/2002 | WO2002028866A2 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | WO2002028865A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028864A1 New process for the production of oxabispidines |
| 04/11/2002 | WO2002028863A1 New oxabispidine compound useful in the treatment of cardiac arrhythmias |
| 04/11/2002 | WO2002028834A1 Process for the preparation of aryl-piperidine carbinols and intermediates thereof |
| 04/11/2002 | WO2001087342A3 Delivery devices for treatment of vascular disease |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | US20020042411 Condensed thiophene compounds and pharmaceutical use thereof |
| 04/11/2002 | CA2423898A1 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 04/11/2002 | CA2423888A1 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | CA2423312A1 Condensed pyridoindole derivatives |
| 04/11/2002 | CA2422810A1 New oxabispidine compound useful in the treatment of cardiac arrhythmias |
| 04/11/2002 | CA2421776A1 New process for the production of oxabispidines |
| 04/10/2002 | EP1194135A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
| 04/10/2002 | EP0918774B9 Androgen receptor modulator compounds and methods |
| 04/10/2002 | EP0813535B1 Hexacyclic camptothecin analogues, and process for preparing them |
| 04/10/2002 | EP0712402B1 Hydroisoquinoline derivatives |
| 04/09/2002 | US6369227 Thrombin or factor Xa inhibitors |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369070 Methods for inhibiting mrp1 |
| 04/09/2002 | US6369056 Agonists and antagonists of the progesterone receptor; contraceptives; 6-(3-chlorophenyl)-4,4-dimethyl-1,4-dihydro -3-oxa-1,8-diaza-naphthalene-2-one and 6-chloro-4,4-dimethyl-1,4-dihydro-3-oxa-1,5-diaza-naphthalen-2-one |
| 04/09/2002 | US6369002 Hetero is pyrimidine or pyridazine; 1-(3-fluoro-5-chloro pyridin-2-yl)-3-methyl-4-trifluoromethylpyrimidin-2,6-dione |
| 04/09/2002 | US6368520 Synergistic stabilizer mixture |